EJ
Eric Joseph JP Morgan Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Kymera Therapeutics
KYMR
$3.15B
| $44.04 | $64 |
45%
upside
| Overweight |
3 Jun ‘25
3 months ago |
|
2
Rocket Pharmaceuticals
RCKT
$340M
| $3.15 | $44 |
1,297%
upside
| Overweight |
9 May ‘25
4 months ago |
|
3
Novavax
NVAX
$1.26B
| $7.76 | $7 |
10%
downside
| Underweight |
9 May ‘25
4 months ago |
|
4
PTC Therapeutics
PTCT
$4.62B
| $58.20 | $67 |
15%
upside
| Overweight |
7 May ‘25
4 months ago |
|
5
Nurix Therapeutics
NRIX
$690M
| $9.02 | $30 |
233%
upside
| Overweight |
29 Jan ‘25
7 months ago |
|
6
Vir Biotechnology
VIR
$710M
| $5.11 | $14 |
174%
upside
| Neutral |
9 Jan ‘25
8 months ago |
|
7
Revolution Medicines
RVMD
$7.68B
| $41.07 | $71 |
73%
upside
| Overweight |
3 Dec ‘24
9 months ago |
|
8
TG Therapeutics
TGTX
$5.08B
| $32.04 | $43 |
34%
upside
| Overweight |
25 Nov ‘24
9 months ago |
|
|
SEPN
9
Septerna, Inc. Common Stock
SEPN
$653M
| $14.65 | $38 |
159%
upside
| Overweight |
19 Nov ‘24
9 months ago |
|
10
CAMP4 Therapeutics Corporation Common Stock
CAMP
$37.9M
| $1.88 | $23 |
1,123%
upside
| Overweight |
5 Nov ‘24
10 months ago |
|
11
Wave Life Sciences
WVE
$1.19B
| $7.50 | $17 |
127%
upside
| Overweight |
17 Oct ‘24
10 months ago |
|
12
Relay Therapeutics
RLAY
$697M
| $4.04 | $21 |
420%
upside
| Overweight |
10 Sep ‘24
1 year ago |
|
13
Beam Therapeutics
BEAM
$1.99B
| $19.63 | $48 |
145%
upside
| Overweight |
7 Aug ‘24
1 year ago |
|
14
Enanta Pharmaceuticals
ENTA
$189M
| $8.85 | $10 |
13%
upside
| Underweight |
6 Aug ‘24
1 year ago |
|
15
Biomea Fusion
BMEA
$107M
| $1.80 | $15 |
733%
upside
| Neutral |
3 May ‘24
1 year ago |
|
16
C4 Therapeutics
CCCC
$191M
| $2.69 | $6 |
123%
upside
| Neutral |
29 Jan ‘24
1 year ago |
|
17
Recursion Pharmaceuticals
RXRX
$2.02B
| $4.63 | $10 |
116%
upside
| Neutral |
13 Nov ‘23
1 year ago |
|
18
Monte Rosa Therapeutics
GLUE
$297M
| $4.81 | $11 |
129%
upside
| Overweight |
19 Oct ‘23
1 year ago |
|
19
Akero Therapeutics
AKRO
$3.52B
| $44.04 | $41 |
7%
downside
| Overweight |
11 Oct ‘23
1 year ago |
|
20
Lyell Immunopharma
LYEL
$253M
| $13.15 | $100 |
660%
upside
| Neutral |
28 Aug ‘23
2 years ago |
|
21
Century Therapeutics
IPSC
$43.6M
| $0.5050 | $5 |
890%
upside
| Neutral |
28 Aug ‘23
2 years ago |
|
22
Terns Pharmaceuticals
TERN
$641M
| $7.33 | $11 |
50%
upside
| Neutral |
9 Aug ‘23
2 years ago |
|
23
Karyopharm Therapeutics
KPTI
$54.9M
| $6.33 | $120 |
1,796%
upside
| Neutral |
9 Feb ‘22
3 years ago |
|
24
Aligos Therapeutics
ALGS
$77.6M
| $11.17 | $300 |
2,586%
upside
| Neutral |
7 Jan ‘22
3 years ago |
|
|
AUTL
25
Autolus Therapeutics
AUTL
$367M
| $1.38 | $9 |
552%
upside
| Neutral |
29 Jan ‘21
4 years ago |
|